Diphenylhydantoin antibody
Ref. 3D-20-RDIWDPH
| 1ml | 175,00 € |
Produktinformation
The Diphenylhydantoin antibody is a powerful monoclonal antibody that targets multidrug resistance in cancer cells. It specifically binds to diphenylhydantoin, a commonly used antiepileptic drug, and blocks its efflux from cancer cells. This antibody has shown promising results in increasing the efficacy of chemotherapy by reversing drug resistance.
In addition to its role in multidrug resistance, the Diphenylhydantoin antibody has been found to have other therapeutic applications. It inhibits the activity of adrenomedullin, a peptide hormone involved in angiogenesis, and reduces microvessel density in tumors. Furthermore, this antibody interacts with glucagon and tumor necrosis factor-alpha (TNF-α), two key players in inflammation and immune response.
The Diphenylhydantoin antibody is highly specific and exhibits minimal cross-reactivity with other compounds. It is available as a polyclonal antibody, ensuring high affinity and specificity for its target. Researchers
Chemische Eigenschaften
Technische Anfrage zu: 3D-20-RDIWDPH Diphenylhydantoin antibody
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
